Skip to main content
Premium Trial:

Request an Annual Quote

SeqLL to Raise $1.8M in Direct Stock Offering

NEW YORK – SeqLL said on Monday that it has priced a $1.8 million registered direct stock offering.

The Billerica, Massachusetts-based sequencing instrument and services firm said it has entered into a securities purchase agreement with unnamed institutional investors for a registered direct offering that is expected to raise $1.8 million in gross proceeds.

The company is offering 2 million shares of its common stock at a purchase price of $.90 per share in the offering. It did not specify the intended use of the funding.

Maxim Group is acting as the sole placement agent in connection with the offering, which is expected to close on or about Feb. 15, subject to customary closing conditions.

In midday trading on the Nasdaq, SeqLL's stock was down 20 percent, at $1.06 per share, after rising sharply last week when the company announced a collaboration with the FBI on forensics technology.

The Scan

ChatGPT Does As Well As Humans Answering Genetics Questions, Study Finds

Researchers in the European Journal of Human Genetics had ChatGPT answer genetics-related questions, finding it was about 68 percent accurate, but sometimes gave different answers to the same question.

Sequencing Analysis Examines Gene Regulatory Networks of Honeybee Soldier, Forager Brains

Researchers in Nature Ecology & Evolution find structural network differences between soldiers and foragers, suggesting bees can take on either role.

Analysis of Ashkenazi Jewish Cohort Uncovers New Genetic Loci Linked to Alzheimer's Disease

The study in Alzheimer's & Dementia highlighted known genes, but also novel ones with biological ties to Alzheimer's disease.

Tara Pacific Expedition Project Team Finds High Diversity Within Coral Reef Microbiome

In papers appearing in Nature Communications and elsewhere, the team reports on findings from the two-year excursion examining coral reefs.